Where does DOMPÈ Farmaceutici S.P.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), DOMPÈ Farmaceutici S.P.A. ranks #10,307 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does DOMPÈ Farmaceutici S.P.A. hold?

DOMPÈ Farmaceutici S.P.A. holds 30 US utility patents granted between 2016 and 2025, spanning 16 technology areas.

What is DOMPÈ Farmaceutici S.P.A.'s Innovation Score?

DOMPÈ Farmaceutici S.P.A. has an Innovation Score of 45.7 out of 100 (top 22% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does DOMPÈ Farmaceutici S.P.A. focus on?

DOMPÈ Farmaceutici S.P.A.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 23 patents, ranking #848 of 6,058 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

Is DOMPÈ Farmaceutici S.P.A.'s patent grant rate increasing or decreasing?

DOMPÈ Farmaceutici S.P.A.'s recent grant velocity is -8% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for DOMPÈ Farmaceutici S.P.A.'s patents?

DOMPÈ Farmaceutici S.P.A.'s patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the DOMPÈ Farmaceutici S.P.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

DOMPÈ Farmaceutici S.P.A.

USPTO PatentsView assignee record - 30 granted patents across 16 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dompè ranks #10,307 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 16 technology areas.

#10,307
of 49,997 US assignees by volume: Top 22%
by Innovation Score (45.7/100): 14.3
avg claims per patent: -8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10307 · Foreign Corporation #10,307 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 30 grants
UPPER-Q #10,307/49,997
PHOTO-FINISH Cummins Enterprise
CPC-FOCUS A61P · 16 areas
INNOV-PAR 45.7/100
CLAIMS-RICH 14.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT -8% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cummins Enterprise LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dompè’s 45.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.9 pts (26%) Velocity 11.1 pts (24%) Breadth 14.1 pts (31%) Claim depth 8.6 pts (19%)

Qualcomm Incorporated · highest

85
August Home · near

46
Canyon Bicycles · near

46
Century Technology… · near

46
DOMPÈ Farmaceutici… · this assignee

46
Macrogenics · near

46
3D Lighting… · lowest

7

What this shows Dompè's Innovation Score is 45.7/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Dompè?

Each dot is one of Dompè’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dompè’s own 14.3 claims/patent is ABOVE the 13.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Dompè vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dompè's grants concentrate

DOMPÈ Farmaceutici S.P.A. is a focused PatentsView assignee: 16 CPC subclasses with 76.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (6 grants) versus a trough of 1 in 2023. By volume, Dompè sits between Cummins Enterprise LLC and Desprez LLC.

Dompè's three-year grant acceleration

DOMPÈ Farmaceutici S.P.A. shows 10 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cummins Enterprise

30
Dayco Europe S R L

30
DG International…

30
DN Solutions

30
Dreco Energy Serv…

30
DWS S R L

30
Dart Neuroscience…

30
Desprez

30
DOMPÈ Farmaceutic… ◀

30

What this shows DOMPÈ holds 30 patents at rank #10,304, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near DOMPÈ

By rank, the assignees closest to #10,304 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in DOMPÈ's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for DOMPÈ, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), DOMPÈ ranks #848 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Canyon Bicycles GmbH 46 August Home, Inc. 46 Century Technology (Shenzhen) Corporation Limited 46 Macrogenics, Inc. 46

Dompè's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

DOMPÈ Farmaceutici S.P.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	5	16.7%
2017	2	6.7%
2018	2	6.7%
2019	4	13.3%
2021	2	6.7%
2022	3	10.0%
2023	1	3.3%
2024	6	20.0%
2025partial year	5	16.7%

Which technologies does DOMPÈ Farmaceutici S.P.A. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 23

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 20

C07D - Heterocyclic Compounds 9

C07C - Acyclic OR Carbocyclic Compounds 6

C07K - Peptides 6

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 4

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 1

F26B - Drying Solid Materials OR Objects BY Removing Liquid Therefrom 1

B21D - Working OR Processing OF Sheet Metal OR Metal Tubes, Rods OR Profiles Without Essentially Removing MATERIAL; Punching Metal 1

Y10T - Technical Subjects Covered BY Former US Classification 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

DOMPÈ Farmaceutici S.P.A.'s patent record in context - here's where to go next.

DOMPÈ Farmaceutici S.P.A.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 76.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #10,307 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare DOMPÈ Farmaceutici S.P.A. against Cummins Enterprise LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.